US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 12.370
  • -0.110-0.88%
Close Apr 26 16:00 ET
  • 12.370
  • 0.0000.00%
Post 16:20 ET
261.70MMarket Cap-1882P/E (TTM)

Enanta Pharmaceuticals Key Stats

Enanta Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings Estimates

May 6, 2024

Revenue(YoY)

16.21M

-8.92%
EPS(YoY)

-1.30

+27.45%

Buy

Mar 31, 2024

Enanta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 16.768M--
May 6, 20242024/Q2-- / 16.207M--
Feb 7, 20242024/Q118.003M / 21.946M--
Nov 20, 20232023/Q418.932M / 17.498M--
Aug 7, 20232023/Q318.892M / 16.736M--
May 8, 20232023/Q217.795M / 19.058M--
Feb 7, 20232023/Q123.585M / 22.478M--
Nov 21, 20222022/Q420.317M / 23.132M--
Aug 8, 20222022/Q319.479M / 20.734M--
May 9, 20222022/Q218.716M / 20.671M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 16.768M--
May 6, 20242024/Q2-- / 16.207M--
Feb 7, 20242024/Q118.003M / 21.946M--
Nov 20, 20232023/Q418.932M / 17.498M--
Aug 7, 20232023/Q318.892M / 16.736M--
May 8, 20232023/Q217.795M / 19.058M--
Feb 7, 20232023/Q123.585M / 22.478M--
Nov 21, 20222022/Q420.317M / 23.132M--
Aug 8, 20222022/Q319.479M / 20.734M--
May 9, 20222022/Q218.716M / 20.671M--

Unlock Free Earnings Estimates

Enanta Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Buy

  • Buy

    50.00%
  • Hold

    33.33%
  • Sell

    16.67%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg